ReviewDiagnostics (Basel, Switzerland)2026
Diagnostic Role and Clinical Impact of Zr-Girentuximab PET-CT for the Diagnosis and Treatment of Clear-Cell Renal Cell Carcinoma.
Daniel A González-Padilla, Felipe Villacampa-Auba, Jorge Caño-Velasco, José Daniel Subiela, María Rodríguez, Carlos Yánez, Andrés Calva, Vanessa Talavera, Carmina Muñoz, Marcos Torres and 5 more
Abstract readReview
In one paragraphReview in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
15 authors.
Daniel A González-PadillaDepartment of Urology, Kidney and Bladder Cancer Unit, Clínica Universidad de Navarra, 28027 Madrid, Spain.ORCID 0000-0002-5853-8845 Felipe Villacampa-AubaDepartment of Urology, Kidney and Bladder Cancer Unit, Clínica Universidad de Navarra, 28027 Madrid, Spain.ORCID 0000-0001-6779-6945 Jorge Caño-VelascoDepartment of Urology, Kidney and Bladder Cancer Unit, Clínica Universidad de Navarra, 31008 Pamplona, Spain.ORCID 0000-0003-0498-8602 José Daniel SubielaDepartment of Urology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Universidad de Alcalá, 28034 Madrid, Spain.ORCID 0000-0003-4176-8174 María RodríguezDepartment of Urology, Kidney and Bladder Cancer Unit, Clínica Universidad de Navarra, 31008 Pamplona, Spain.
Carlos YánezDepartment of Urology, Kidney and Bladder Cancer Unit, Clínica Universidad de Navarra, 31008 Pamplona, Spain.
Andrés CalvaDepartment of Urology, Kidney and Bladder Cancer Unit, Clínica Universidad de Navarra, 31008 Pamplona, Spain.ORCID 0009-0006-2503-9368 Vanessa TalaveraDepartment of Urology, Kidney and Bladder Cancer Unit, Clínica Universidad de Navarra, 31008 Pamplona, Spain.ORCID 0009-0000-2425-9795 Carmina MuñozDepartment of Urology, Kidney and Bladder Cancer Unit, Clínica Universidad de Navarra, 28027 Madrid, Spain.ORCID 0009-0000-1175-5706 Marcos TorresDepartment of Urology, Kidney and Bladder Cancer Unit, Clínica Universidad de Navarra, 31008 Pamplona, Spain.
Guillermo BarbasDepartment of Urology, Kidney and Bladder Cancer Unit, Clínica Universidad de Navarra, 28027 Madrid, Spain.ORCID 0000-0002-6532-663X Guillermo AndrésDepartment of Urology, Kidney and Bladder Cancer Unit, Clínica Universidad de Navarra, 28027 Madrid, Spain.
Daniel Sánchez-ZalabardoDepartment of Urology, Kidney and Bladder Cancer Unit, Clínica Universidad de Navarra, 31008 Pamplona, Spain.ORCID 0009-0003-1803-580X Edgar Fernando Guillén-ValderramaDepartment of Nuclear Medicine, Clínica Universidad de Navarra, 28027 Madrid, Spain.
Bernardino Miñana-LópezDepartment of Urology, Kidney and Bladder Cancer Unit, Clínica Universidad de Navarra, 28027 Madrid, Spain.ORCID 0000-0001-7745-5650 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
carbonic anhydrase IXgirentuximabPET-CTrenal cell carcinomaZIRCON
Identifiers
PMID42122026
PMCPMC13163076
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390